Prometra II^® is the new programmable pump for the continuous subarachnoid administration of medication for the treatment of pain and alleviation of spasticity.

Indications:

• Refractory syndrome to chronic cancer and non-cancer pain
• Spasticity

Features & Advantages:

• New: The device has been integrated with the patented FAV^TM (flow-activated valve) safety system. This technology can safely suspend drug infusion, in ordinary and in emergency mode, allowing patients to undergo diagnostic tests like Magnetic Resonance Imaging*
• Powered by lithium battery that gives the device a lifespan of up to 12 years
• 97% drug delivery accuracy. This makes the system extremely precise and safe in delivering programmed therapy, minimizing the risk of infusion errors that might be harmful for the patient
• Mechanical components made entirely from titanium, ensuring safe and stable pharmacological infusion even over the long term
• Therapy delivery range from 0.0 ml/24h to 28.8 ml/24h. This feature makes Prometra II^® a highly sought-after instrument thanks to its versatility in meeting the needs of every single patient
• The only device on the market that can suspend therapeutic administration (0 ml/24h) for as long as necessary without compromising the functionality of machine and battery